To the Editor

Abstract

Get full access to this article

View all access options for this article.

References

TIMI Study Group. The thrombolysis in myocardial infarction (TIMI) trial: Phase I findings. N Engl J Med 1985; 312: 932–6.

Schroder

Biamino

Enz-Rudiger

. Intravenous short-term infusion of streptokinase in acute myocardial infarction. Circulation 1983; 67: 536–48.

Koren

Weiss

Hasin

. Prevention of myocardial damage in acute myocardial ischemia by early treatment with intravenous streptokinase. N Engl J Med 1985; 313: 1384–9.

European Cooperative Study Group for Recombinant Tissue-Type Plasminogen Activator. Randomized trial of intravenous recombinant tissue-type plasminogen activator versus intravenous streptokinase in acute myocardial infarction. Lancet 1985; 1: 842–7.

Anderson

Marshall

Skins

. A randomized trial of intravenous and intracoronary streptokinase therapy in patients with acute myocardial infarction. Circulation 1984; 70: 606–18.

Taylor

Mikell

Moses

. Intravenous versus intracoronary streptokinase therapy for acute myocardial infarction in community hospitals. Am J Cardiol 1984; 54: 256–60.

Alderman

Jutzy

Berte

. Randomized comparison of intravenous versus intracoronary streptokinase therapy for myocardial infarction. Am J Cardiol 1984; 54: 14–9.

Spann

Sherry

Carabello

. Coronary thrombolysis by intravenous streptokinase in acute myocardial infarction: Acute and follow-up studies. Am J Cardiol 1984; 53: 655–61.

Neuhaus

Tebbe

Sauer

Rahlf

Kreuzer

Kostering

. Hochdosierte intravenose kurzinfusion von streptokinase beim akuten myokardinfarkt. In: Trubestein

Etzel

, eds. Fibrinolytische therapie. Stuttgart-New York: FK Shattauer Verlag, 1983: 425–30.

10.

Rogers

Mantle

Hood

. Prospective randomized trial of intracoronary and intravenous streptokinase in acute myocardial infarction. Circulation 1983; 68: 1051–61.

11.

Chesebro

Knatterud

Roberts

. Thrombolysis in myocardial infarction (TIMI) trial, phase I: A comparison between intravenous tissue plasminogen activator and intravenous streptokinase. Circulation 1987; 76: 142–54.

12.

BRAUNWALD E, KNATTERUD GL, PASSAMANI ER, ROBERTSON TL, and TIMI Operations Committee. Announcement of protocol change in thrombolysis in myocardial infarction trial. J Am Coll Cardiol 1987; 9: 467.

13.

Gruppo Italiano per lo Studio Della Streptochinasi Nell'Infarcto Miocardio (GISSI). Effectiveness of intravenous thrombolytic treatment in acute myocardial infarction. Lancet 1986; 1: 397–401.

14.

ISIS Steering Committee. Intravenous streptokinase given within 0–4 hours of onset of myocardial infarction reduced mortality rate in ISIS-2 (letter). Lancet 1987; 1: 502.

15.

ISAM Study Group. A prospective trial of intravenous streptokinase in acute myocardial infarction (ISAM). Mortality, morbidity and infarct size at 21 days. N Engl J Med 1986; 314: 1465–71.